Literature DB >> 9065567

Comparison of African-American and white persons with Alzheimer's disease on language measures.

D N Ripich1, B Carpenter, E Ziol.   

Abstract

We assessed 11 African-American and 32 white subjects with early to midstage AD using seven measures (the Boston Naming Test, Peabody Picture Vocabulary Test-Revised, Shortened Token Test, a modified Reporter's Test, two subtests of a shortened Rey Auditory Verbal Learning Test, and selected stimuli from the Test of Problem Solving). There were no ethnic differences, with Mini-Mental State Examination score and education accounting for most of the variance between ethnic groups. However, white subjects tended to score higher than African-Americans on five of the seven measures. African-Americans tended to perform better on the Test of Problem Solving, a measure of the pragmatic use of language. Although these preliminary findings suggest no test bias for ethnicity, the trends indicate that language measures should continue to be examined for ethnic differences in larger samples.

Entities:  

Mesh:

Year:  1997        PMID: 9065567     DOI: 10.1212/wnl.48.3.781

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Characterizing and explaining differences in cognitive test performance between african american and European American older adults.

Authors:  Adrienne Aiken Morgan; Michael Marsiske; Keith E Whitfield
Journal:  Exp Aging Res       Date:  2008 Jan-Mar       Impact factor: 1.645

2.  Race-related cognitive test bias in the active study: a mimic model approach.

Authors:  Adrienne T Aiken Morgan; Michael Marsiske; Joseph M Dzierzewski; Richard N Jones; Keith E Whitfield; Kathy E Johnson; Mary K Cresci
Journal:  Exp Aging Res       Date:  2010-10       Impact factor: 1.645

3.  Preliminary assessment of connected speech and language as marker for cognitive change in late middle-aged Black/African American adults at risk for Alzheimer's disease.

Authors:  Elizabeth Evans; Sheryl L Coley; Diane C Gooding; Nia Norris; Celena M Ramsey; Gina Green-Harris; Kimberly D Mueller
Journal:  Aphasiology       Date:  2021-06-18       Impact factor: 1.902

4.  Donepezil for the treatment of language deficits in adults with Down syndrome: a preliminary 24-week open trial.

Authors:  James H Heller; Gail A Spiridigliozzi; Jennifer A Sullivan; P Murali Doraiswamy; Ranga R Krishnan; Priya S Kishnani
Journal:  Am J Med Genet A       Date:  2003-01-15       Impact factor: 2.802

5.  Screening for Specific Language Impairment in Preschool Children: Evaluating a Screening Procedure Including the Token Test.

Authors:  Ulrike Willinger; Michaela Schmoeger; Matthias Deckert; Brigitte Eisenwort; Benjamin Loader; Annemarie Hofmair; Eduard Auff
Journal:  J Psycholinguist Res       Date:  2017-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.